MLN2704 in Treating Patients With Progressive Metastatic Prostate Cancer
This study has been completed.
Memorial Sloan-Kettering Cancer Center
Information provided by:
National Cancer Institute (NCI)
First received: April 7, 2003
Last updated: February 6, 2009
Last verified: April 2005
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||No date given|
Galsky MD, Eisenberger M, Moore-Cooper S, Kelly WK, Slovin SF, DeLaCruz A, Lee Y, Webb IJ, Scher HI. Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer. J Clin Oncol. 2008 May 1;26(13):2147-54. Epub 2008 Mar 24.